How is oral minoxidil taken?

Tablet strengths and labelled doses
Label figure (high blood pressure, patients over 12 years of age)Dose and schedule
Tablet strengths2.5 mg or 10 mg1
Starting dose5 mg as a single daily dose1
StepsDaily dose can be increased to 10, 20 and then 40 mg, in single or divided doses, if required for optimum blood pressure control1
Usual effective range10 to 40 mg per day1
Maximum100 mg per day1

The US minoxidil tablet label, for high blood pressure in patients over 12 years of age, gives 5 mg as a single daily dose to start, which can be increased to 10, 20 and then 40 mg in single or divided doses if required for optimum blood pressure control, while a 2020 review by Jimenez-Cauhe and colleagues of 14 studies including 442 patients found oral minoxidil used for hair loss at doses between 0.25 and 5 mg.12

Tablet strengths and labelled doses

The table is set at the top of the page

Hair loss is not among the tablet label's uses, and a review by Dias and colleagues says that, unlike topical minoxidil, the oral and sublingual formulations are not FDA-approved and only prescribed off-label.13 The label says the drug need be given only once a day if supine diastolic pressure has been reduced less than 30 mm Hg, and that the daily dose is divided into two equal parts if it has been reduced more than 30 mm Hg.1 The label says the tablets are indicated only in the treatment of hypertension that is symptomatic or associated with target organ damage and is not manageable with maximum therapeutic doses of a diuretic plus two other antihypertensive drugs.1

The label gives no instruction to mix or reconstitute the tablets, and the searches found no label for a capsule or an oral powder.1

Doses used in hair-loss studies

TrialDose and schedulePeopleLength
Penha and colleagues, 2024 (double-blind, placebo-controlled, randomised, Brazil)Oral 5 mg daily with a topical placebo, or 1 mL of 5% topical twice daily with an oral placebo90 men enrolled, 68 completed24 weeks4
Panchaprateep and Lueangarun, 2020 (open-label, one arm)Oral 5 mg once dailyThirty men aged 24–59 years24 weeks5
Asilian and colleagues, 2024 (randomised)Oral 1 mg/day, or 5% topical solutionSixty-five patients6 months6
Tang and colleagues, 2026 (randomised, double-blind, placebo-controlled; transgender people on testosterone with mild androgenetic alopecia)Sublingual 1.35 mg twice daily or placebo, then sublingual 2.5 mg twice daily for all in an open-label extensionForty-six people (23 per arm)24 weeks before the extension7

A double-blind randomised trial of oral minoxidil 2.5 mg versus 5 mg in men with androgenetic alopecia (Carvalho Fonseca and colleagues, 2026) is listed in PubMed without any results text, so no result or size from it is given here.8

What is known about stepping hair-loss doses

A retrospective multicentre study by Vañó-Galván and colleagues (2021) of 1404 patients (943 women, 461 men) treated with low-dose oral minoxidil for at least 3 months for any type of alopecia titrated the dose in 1065 of them.9 In a 2025 modified Delphi consensus by Akiska and colleagues, 43 hair loss specialist dermatologists from 12 countries took part, and titration protocols for low-dose oral minoxidil fell short of consensus.10 The Dias review in Frontiers in Pharmacology says further large-scale, long-term studies are needed to define optimal dosing.3

Topical minoxidil, for comparison

The Men's Rogaine Extra Strength label, a 5% w/v topical solution for use by men only, not for anyone under 18 years of age, and for the top of the scalp (vertex only), directs one mL with dropper 2 times a day directly onto the scalp in the hair loss area.11

Storage

The tablet label says to store the tablets at 20° to 25°C (68° to 77°F).1 No stability data for compounded oral minoxidil were found in the searches.

Warnings and side effects in the label and in studies

The tablet label warns that minoxidil may produce serious adverse effects: it can cause pericardial effusion, occasionally progressing to tamponade, and angina pectoris may be exacerbated.1 It says elongation, thickening, and enhanced pigmentation of fine body hair (hypertrichosis) are seen in about 80% of patients taking minoxidil tablets, a label whose only indication is high blood pressure.1 In hair-loss studies, hypertrichosis was 15.1% in the 1404-patient study by Vañó-Galván and colleagues, 24% of 442 patients in the review by Jimenez-Cauhe and colleagues, 93.3% at 24 weeks among the thirty men on 5 mg once daily in the Panchaprateep and Lueangarun study, and 49% (22 of 45) in the 5 mg oral group of the Penha trial, where headache was 14% (6 of 45).9254

Frequently asked questions

Can minoxidil tablets be split?

The label lists the 2.5 mg tablets as scored, and its patient leaflet says a doctor may prescribe half a tablet and that the tablets are scored (partly cut on one side) so that they can easily be broken.1 Nothing in the searches states how to halve or quarter tablets for hair-loss doses.

Is there a minoxidil cycle or a beard dose?

The searches found no description of a minoxidil cycle and no label or trial for beard use.

What do Milligram users log for minoxidil?

Milligram has no logged minoxidil figure at its reporting floor.

References

  1. NuCare Pharmaceuticals (DailyMed). Minoxidil Tablets, USP Rx only. 2026. dailymed.nlm.nih.gov
  2. Dermatol Ther. Safety of low-dose oral minoxidil treatment for hair loss. A systematic review and pooled-analysis of individual patient data. 2020. pubmed.ncbi.nlm.nih.gov
  3. Front Pharmacol. Expanding the therapeutic landscape of minoxidil for androgenetic alopecia: topical, oral and sublingual formulations. 2026. pmc.ncbi.nlm.nih.gov
  4. PubMed. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. 2024. pubmed.ncbi.nlm.nih.gov
  5. Dermatol Ther (Heidelb). Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment. 2020. pmc.ncbi.nlm.nih.gov
  6. J Cosmet Dermatol. Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial. 2024. pubmed.ncbi.nlm.nih.gov
  7. J Am Acad Dermatol. Treatment of androgenetic alopecia in transgender people receiving testosterone therapy with sublingual minoxidil: A randomized, double-blind, placebo-controlled clinical trial. 2026. pubmed.ncbi.nlm.nih.gov
  8. J Am Acad Dermatol. Oral minoxidil 2.5 mg versus 5 mg for male androgenetic alopecia: A double-blind randomized clinical trial. 2026. pubmed.ncbi.nlm.nih.gov
  9. J Am Acad Dermatol. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. 2021. pubmed.ncbi.nlm.nih.gov
  10. PubMed. Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement. 2025. pubmed.ncbi.nlm.nih.gov
  11. Kenvue (DailyMed). MEN'S Rogaine ® EXTRA STRENGTH UNSCENTED. 2026. dailymed.nlm.nih.gov